Nipocalimab is Making Progress in Four Clinical Trials for Autoimmune and Alloimmune Conditions
An investigative therapy for hemolytic disease of the fetus and newborn (HDFN) has just received the FDA's Rare Pediatric Disease and Orphan Drug Designations. This therapy is called nipocalimab and…